MoonLake Immunotherapeutics Current Ratio in % from Q3 2021 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
MoonLake Immunotherapeutics quarterly Current Ratio history and growth rate from Q3 2021 to Q3 2025.
  • MoonLake Immunotherapeutics Current Ratio for the quarter ending September 30, 2025 was 1.51K %, a 63.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)

MoonLake Immunotherapeutics Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 1.51K -2.62K -63.4% Sep 30, 2025
Q2 2025 2.08K -3K -59.1% Jun 30, 2025
Q1 2025 2.58K -3.14K -54.9% Mar 31, 2025
Q4 2024 3.26K -1.32K -28.8% Dec 31, 2024
Q3 2024 4.13K +583 +16.4% Sep 30, 2024
Q2 2024 5.08K +2.45K +93.3% Jun 30, 2024
Q1 2024 5.71K +4.38K +330% Mar 31, 2024
Q4 2023 4.58K +4.4K +2556% Dec 31, 2023
Q3 2023 3.55K +3.42K +2553% Sep 30, 2023
Q2 2023 2.63K +2.53K +2578% Jun 30, 2023
Q1 2023 1.33K +1.27K +2241% Mar 31, 2023
Q4 2022 172 +114 +194% Dec 31, 2022
Q3 2022 134 -107 -44.4% Sep 30, 2022
Q2 2022 98.1 Jun 30, 2022
Q1 2022 56.8 Mar 31, 2022
Q4 2021 58.5 Dec 31, 2021
Q3 2021 241 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.